Clinical Trials for Relapsed or Refractory B-cell Malignancies

Find clinical trials for relapsed or refractory b-cell malignancies. Discover research opportunities and treatment options in your area.

1 Active Trial Found

Showing 1 trial on this page

Page 1 of 1

Dose Determining Study of EXS73565 in Participants With Relapsed or Refractory B-Cell Malignancies

NCT ID: NCT06980116

This clinical trial is testing a new drug called EXS73565 for patients with certain types of B-cell cancers that have come back after treatment or did not respond to previous therapies. The main go...

Recruiting

Phase: PHASE1 Type: interventional Locations: Madrid, , Spain, Plymouth, , United Kingdom +1 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions